Cardiac sarcoidosis: Diagnostic and therapeutic algorithms: Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin (DGP) and Deutsche Gesellschaft für Kardiologie - Herz- und Kreislaufforschung (DGK);Diagnostik und Therapie der kardialen Sarkoidose: Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin (DGP) und Deutsche Gesellschaft für Kardiologie - Herz- und Kreislaufforschung (DGK)

Pneumologie

Volumn 68, Issue 2, 2014, Pages 124-132

  Costabel, U ^a   Skowasch, D ^b   Pabst, S ^b   Stork S ^c   Tschope C ^d   Allewelt, M ^e   Worth, H ^f   Muller Quernheim J ^g   Grohe C ^e  

^a RUHRLANDKLINIK   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^e Klinik fur Pneumologie   (Germany)

^f KLINIKUM FÜRTH   (Germany)

^g UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; CARDIOMYOPATHY; CLINICAL DECISION MAKING; DIAGNOSTIC PROCEDURE; HEART ATRIUM FIBRILLATION; HEART VENTRICLE FIBRILLATION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SARCOIDOSIS; TREATMENT INDICATION; CARDIOLOGY; CARDIOMYOPATHIES; GERMANY; HUMAN; PRACTICE GUIDELINE; PULMONOLOGY; SARCOIDOSIS, PULMONARY; STANDARDS;

ALGORITHMS; CARDIOLOGY; CARDIOMYOPATHIES; GERMANY; HUMANS; PRACTICE GUIDELINES AS TOPIC; PULMONARY MEDICINE; SARCOIDOSIS, PULMONARY;

EID: 84893596973     PISSN: 09348387     EISSN: 14388790     Source Type: Journal    
DOI: 10.1055/s-0033-1359197     Document Type: Article

References (81)

1. Hiraga H., Hiroe M., Iwai K. Guideline for diagnosis of cardiac sarcoidosis: Study report on diffuse pulmonary diseases (in Japanese). Tokyo The Japanese Ministry of Health and Welfare: 1993; 23 24
2. Soejima K., Yada H. The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities. J Cardiovasc Eletrophysiol: 2009; 20 578 583
3. Pabst S., Skowasch D., Grohé C. Sarkoidose. Pneumologie: 2012; 66 96 109
4. Pabst S., Tuleta I., Grohé C. Kardiale Sarkoidose. Kardiologe: 2008; 2 299 311
5. Schulte W., Costabel U., Kirsten D. Kardiale Sarkoidose. Pneumologie: 2003; 57 752 760 (Pubitemid 38102067)
6. Pietinalho A., Hiraga Y., Hosoda Y. et al. The frequency of sarcoidosis in Finland and Hokkaido, Japan: a comparative epidemiological study. Sarcoidosis Diff Vasc: 1995; 12 61 67
7. Deubelbeiss U., Gemperli A., Schindler C. et al. Prevalence of sarcoidosis in Switzerland is associated with environmental factors. Eur Respir J: 2010; 35 1088 1097
8. Iwai K., Tachibana T., Takemura T. et al. Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn: 1993; 43 372 376 (Pubitemid 23225816)
9. Reid J. D. Sarcoidosis in coroner's autopsies: a critical evaluation of diagnosis and prevalence from Cuyahoga County, Ohio. Sarcoidosis Vasc Diffuse Lung Dis: 1998; 15 44 51 (Pubitemid 28174896)
10. Pollak B. Epidemiology of sarcoidosis in Canada. Acta Med Scand Suppl: 1964; 425 145
11. Kitaichi M. Prevalence of sarcoidosis around the world. Sarcoidosis Vasc Diffuse Lung Dis: 1998; 15 16 18
12. Rybicki B. A., Major M., Popovich J. Jr et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol: 1997; 145 234 241
13. Roberts W. C., McAllister H. S. Jr, Ferrans V. J. et al. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients and review of 78 previously described necropsy patients. Am J Med: 1977; 63 86 108 (Pubitemid 8146656)
14. Kim J. S., Judson M. A., Donnino R. et al. Cardiac sarcoidosis. Am Heart J: 2009; 157 9 21
15. Youssef G., Beanlands R. SB, Birnie D. H. et al. Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment. Heart: 2011; 97 2078 2087
16. Shigemitsu H., Nagai S., Sharma O. P. Pulmonary hypertension and granulomatous vasculitis in sarcoidosis. Curr Opin Pulm Med: 2007; 13 434 438 (Pubitemid 47472307)
17. Chapelon-Abric C., de Zuttere D., Duhaut P. et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore): 2004; 83 315 334 (Pubitemid 39541109)
18. Fleming H. A., Baily S. M. Sarcoid heart disease. J R Coll Physicians London: 1981; 15 245 246
19. Matsui Y., Iwai K., Tachibana T. et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann New York Acad Sci: 1976; 278 455 469
20. Smedema J. P., Snoep G., van Kroonenburgh M. P. et al. Cardiac involvement in patients with pulmonary sarcoidosis at two university medical centers in the Netherlands. Chest: 2005; 128 30 35 (Pubitemid 40994450)
21. Yazaki Y., Isobe M., Hiroe M. et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol: 2001; 88 1006 1010 (Pubitemid 33042612)
22. Pabst S., Hammerstingl C., Grau N. et al. Pulmonary Arterial Hypertension in Patients with Sarcoidosis: The Pulsar Single Center Experience. Adv Exp Med Biol: 2013; 755 299 305
23. Iwai K., Sekiguti M., Hosoda Y. et al. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis Diff. Vasc: 1994; 11 26 31
24. Judson M. A., Baughman R. P., Teirstein A. S. et al. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A case control etiologic study of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis: 1999; 16 75 86 (Pubitemid 29164274)
25. Kandolin R., Lehtonen J., Graner M. et al. Diagnosing isolated cardiac sarcoidosis. J Intern Med: 2011; 270 461 468
26. Sulica R., Teirstein A. S., Kakarla S. et al. Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension. Chest: 2005; 128 1483 1489 (Pubitemid 41324436)
27. Baughman R. P., Judson M. A., Teirstein A. et al. Presenting characteristics as predictors of duration of treatment in sarcoidosis. QJM: 2006; 99 307 315
28. Handa T., Nagai S., Miki S. et al. Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest: 2006; 129 1246 1252
29. Bourbonnais J. M., Samavati L. Clinical predictors of pulmonary hypertension in sarcoidosis. Eur Respir J: 2008; 32 296 302
30. Baughman R. P., Engel P. J., Taylor L. et al. Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation. Chest: 2010; 138 1078 1085
31. Nunes H., Humbert M., Capron F. et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax: 2006; 61 68 74 (Pubitemid 43106981)
32. Shlobin O. A., Nathan S. D. Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation. Eur Respir J: 2012; 39 1520 1533
33. Galiè N., Hoeper M. M., Humbert M. et al. ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J: 2009; 30 2493 537
34. Gideon N. M., Mannino D. M. Sarcoidosis mortality in the United States 1979-1991: an analysis of multiple-cause mortality data. Am J Med: 1996; 100 423 427 (Pubitemid 26115197)
35. Baughman R. P., Winget D. B., Bowen E. H. et al. Predicting respiratory failure in sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis: 1997; 14 154 158 (Pubitemid 27427348)
36. Kandolin R., Lehtonen J., Kupari M. Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythm Electrophysiol: 2011; 4 303 309
37. Patel M. R., Cawley P. J., Heitner J. F. et al. Detection of myocardial damage in patients with sarcoidosis. Circulation: 2009; 120 1979 1977
38. Schuller J. L., Olson M. D., Zipse M. M. Electrocardiographic characteristics in patients with pulmonary sarcoidosis indicating cardiac involvement. J Cardiovasc Electrophysiol: 2011; 22 1243 1248
39. Das M. K., Kahn B., Jacob S. et al. Significance of a Fragmented QRS Complex Versus a Q Wave in Patients With Coronary Artery Disease. Circulation: 2006; 113 2495 2501 (Pubitemid 43948027)
40. Silverman K. J., Hutchins G. M., Bulkley B. H. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation: 1978; 58 1204 1211 (Pubitemid 9092005)
41. Burstow D. J., Tajik A. J., Bailey K. R. et al. Two-dimensional echocardiographic findings in systemic sarcoidosis. Am J Cardiol: 1989; 63 478 482 (Pubitemid 19065326)
42. Mehta D., Lubitz S. A., Frankel Z. et al. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest: 2008; 133 1426 1435 (Pubitemid 351893001)
43. Fahy G. J., Marwick T., McCreery C. J. et al. Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis. Chest: 1996; 109 62 66 (Pubitemid 26017594)
44. Schulz-Menger J., Wassmuth R., Abdel-Aty H. et al. Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance. Heart: 2006; 92 399 400
45. Cummings K. W., Bhalla S., Javidan-Nejad C. et al. A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging. Radiographics: 2009; 29 89 103
46. Ichinose A., Otani H., Oikawa M. et al. MRI of cardiac sarcoidosis: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function. AJR Am J Roentgenol: 2008; 191 862 869
47. Smedema J. P., Snoep G., van Kroonenburgh M. P. et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol: 2005; 45 1683 1690 (Pubitemid 40704507)
48. Ohira H., Tsujino I., Ishimaru S. et al. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging: 2008; 35 933 941
49. Pellegrino D., Bonab A. A., Dragotakes S. C. et al. Inflammation and infection: imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG. J Nucl Med: 2005; 46 1522 1530 (Pubitemid 46177970)
50. Tellier P., Valeyre D., Nitenberg A. et al. Cardiac sarcoidosis: reversion of myocardial perfusion abnormalities by dipyridamole. Eur J Nucl Med: 1985; 11 201 204 (Pubitemid 16233601)
51. Tellier P., Paycha F., Antony I. et al. Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis. Am J Med: 1988; 85 189 193
52. Hirose Y., Ishida Y., Hayashida K. et al. Myocardial involvement in patients with sarcoidosis. An analysis of 75 patients. Clin Nucl Med: 1994; 9 522 526 (Pubitemid 24180757)
53. Mana J. Nuclear imaging. 67Gallium, 201thallium, 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography. Clin Chest Med: 1997; 18 799 811 (Pubitemid 27525442)
54. Okayama K., Kurata C., Tawarahara K. et al. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest: 1995; 107 330 334
55. Le Guludec D., Menad F., Faraggi M. et al. Myocardial sarcoidosis. Clinical value of technetium-99m sestamibi tomoscintigraphy. Chest: 1994; 106 1675 1682 (Pubitemid 24375125)
56. Okumura W., Iwasaki T., Toyama T. et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med: 2004; 45 1989 1998 (Pubitemid 47611626)
57. Ishimaru S., Tsujino I., Takei T. et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J: 2005; 26 1538 1543 (Pubitemid 41373496)
58. Tadamura E., Yamamuro M., Kubo S. et al. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol: 2005; 185 110 115
59. Yamagishi H., Shirai N., Takagi M. et al. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. J Nucl Med: 2003; 44 1030 1036 (Pubitemid 39663376)
60. Ardehali H., Howard D. L., Hariri A. et al. A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. Am Heart J: 2005; 150 459 463 (Pubitemid 41317613)
61. Cooper L. T., Baughman K. L., Feldman A. M. et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol: 2007; 50 1914 1931 (Pubitemid 350011209)
62. Aizer A., Stern E. H., Gomes J. A. et al. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am J Cardiol: 2005; 96 276 282 (Pubitemid 40978589)
63. Mehta D., Mori N., Goldbarg S. et al. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation. Circ Arrhythm Electrophysiol: 2011; 4 43 48
64. Date T., Shinozaki T., Yamakawa M. et al. Elevated plasma brain natriuretic peptide level in cardiac sarcoidosis patients with preserved ejection fraction. Cardiology: 2007; 107 277 280 (Pubitemid 46788244)
65. Yasutake H., Seino Y., Kashiwagi M. et al. Detection of cardiac sarcoidosis using cardiac markers and myocardial integrated backscatter. Int J Cardiol: 2005; 102 259 268 (Pubitemid 40854040)
66. Baughman R. P., Culver D. A., Judson M. A. A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med: 2011; 183 573 581
67. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med: 1999; 160 736 755
68. Grutters J. C., van den Bosch J. M. Corticosteroid treatment in sarcoidosis. Eur Respir J: 2006; 28 627 636 (Pubitemid 44794680)
69. Kato Y., Morimoto S., Uemura A. et al. Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block. Sarcoidosis Vasc Diffuse Lung Dis: 2003; 20 133 137 (Pubitemid 36841694)
70. Chiu C. Z., Nakatani S., Zhang G. et al. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol: 2005; 95 143 146 (Pubitemid 40051133)
71. Banba K., Kusano K. F., Nakamuro K. et al. Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis. Heart Rhythm: 2007; 4 1292 1299 (Pubitemid 47457196)
72. Jefic D., Joel B., Good E. et al. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry. Heart Rhyth: 2009; 6 189 195
73. Yodogawa K., Seino Y., Ohara T. et al. Effect of Corticosteroid Therapy on Ventricular Arrhythmias in Patients with Cardiac Sarcoidosis. Ann Noninvasive Electrocardiol: 2011; 16 140 147
74. Epstein A. E., Dimarco J. P., Ellenbogen K. A. et al. ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary. Heart Rhythm: 2008; 5 934 955
75. Oni A. A., Hershberger R. E., Norman D. J. et al. Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. J Heart Lung Transplan: 1992; 11 367 369
76. Viles-Gonzalez J. F., Pastori L., Fischer A. et al. Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications. Chest: 2013; 4 1085 1090
77. Soejima K., Yada H. The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities. J Cardiovasc Electrophysiol: 2009; 20 578 588
78. Kato Y., Morimoto S., Uemura A. et al. Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block. Sarcoidosis Vasc Diffuse Lung Dis: 2003; 20 133 137 (Pubitemid 36841694)
79. Yazaki Y., Isobe M., Hiroe M. et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol: 2001; 88 1006 1010 (Pubitemid 33042612)
80. Iannuzzi M. C., Fontana J. R. Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics. JAMA: 2011; 305 391 299
81. Jefic D. et al. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry. Heart Rhythm: 2009; 6 189 195